International Journal of Hematology

, Volume 91, Issue 1, pp 149–151

Salmonella enteritidis necrotising fasciitis in a multiple myeloma patient receiving bortezomib

  • Andrew Rosser
  • Gillian Swallow
  • R. Andrew Swann
  • Claire Chapman
Letter to the Editor


  1. 1.
    Pegues DA, Ohl ME, Miller SI. Salmonella species including Salmonella typhi. In: Mandell GL, Bennett JE MD Dolin R, editors. Principles and practice of infectious disease 6th ed. Elsevier; Amsterdam; 2005. p. 2636–54.Google Scholar
  2. 2.
    HPA. National increase in Salmonella enteritidis phage type 14b infections in England. Health Protection Report [HPR] Weekly 2009;3(42).
  3. 3.
    Hohmann EL. Nontyphoidal salmonellosis. Clin Infect Dis. 2001;32(2):263–9.CrossRefPubMedGoogle Scholar
  4. 4.
    Wilson B. Necrotizing fasciitis. Am Surg. 1952;18:416–31.PubMedGoogle Scholar
  5. 5.
    Khawcharoenporn T, Apisarnthanarak A, Kiratisin P, Mundy LM. Salmonella group C necrotizing fasciitis: a case report and review of the literature. Diagn Microbiol Infect Dis. 2006;54(4):319–22.CrossRefPubMedGoogle Scholar
  6. 6.
    Tsubokura M, Kami M, Komatsu T. Bortezomib plus melphalan and prednisone for multiple myeloma. N Engl J Med. 2008;359(24):2613.CrossRefPubMedGoogle Scholar
  7. 7.
    Bladé J, Cibeira MT, Rosiñol L. Bortezomib: a valuable new antineoplastic strategy in multiple myeloma. Acta Oncol. 2005;44(5):440–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Tosi P, Gamberi B, Giuliani N. Biology and treatment of multiple myeloma. Biol Blood Marrow Transplant. 2006;12(1 Suppl 1):81–6.CrossRefPubMedGoogle Scholar
  9. 9.
    Broder S, Humphrey R, Durm M, Blackman M, Meade B, Goldman C, et al. Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma role of suppressor cells. N Engl J Med. 1975;293(18):887–92.PubMedCrossRefGoogle Scholar
  10. 10.
    Hsu RB, Chen RJ, Lin FY, Chu SH. Influence of ciprofloxacin resistance on risk factors for endovascular infection in patients with infection due to group C nontyphoid salmonellae. Clin Infect Dis. 2005;40(9):1364–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Albaghdadi H, Robinson N, Finlay B, Krishnan L, Sad S. Selectively reduced intracellular proliferation of Salmonella enterica serovar typhimurium within APCs limits antigen presentation and development of a rapid CD8 T cell response. J Immunol. 2009;183(6):3778–87.CrossRefPubMedGoogle Scholar
  12. 12.
    Basler M, Lauer C, Beck U, Groettrup M. The proteasome inhibitor bortezomib enhances the susceptibility to viral infection. J Immunol. 2009;183:6145–50. [Epub ahead of print].CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2009

Authors and Affiliations

  • Andrew Rosser
    • 1
  • Gillian Swallow
    • 2
  • R. Andrew Swann
    • 1
  • Claire Chapman
    • 2
  1. 1.Department of Medical MicrobiologyUniversity Hospitals of LeicesterLeicesterUK
  2. 2.Department of HaematologyUniversity Hospitals of LeicesterLeicesterUK

Personalised recommendations